Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal JPSCR : Journal of Pharmaceutical Science and Clinical Research Proceeding International Conference on Education
Zulkifli, Iqbal
Unknown Affiliation
Religion Education Environmental Science Public Health Social Sciences Other

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Narratives of Song-Based Teaching: Adaptive Strategies and Motivation in Indonesian EFL Context Zulkifli, Iqbal; Irlina, Andi
Proceeding International Conference on Education Volume 03, Agustus Tahun 2025: International Conference on Education
Publisher : Faculty of Tarbiyah, Institut Agama Islam Negeri (IAIN) Kediri, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This study aimed to explore the experiences and adaptive strategies of English teachers for using songs as media in their teaching practices. A qualitative study method with a narrative inquiry approach was applied. Two English teachers from different junior high schools in Banjarmasin were selected as participants. Data was collected through in-depth interviews and supported by classroom observations. The findings revealed that teachers adapted their song-based instruction to suit students’ levels, interests, and classroom dynamics, creating a flexible and engaging environment. The teachers’ motivation to continue using songs emerged from their own enjoyment, increased confidence, and positive student responses, including better participation and language proficiency. The use of song as media also proved technically simple and did not require formal training, making it accessible for broader classroom use. This study highlights the importance of adaptive pedagogical choices and recommends the use of song as a responsive and motivating medium to enhance both teaching effectiveness and student engagement in EFL classrooms.
Drug Repurposing for Monkeypox: An Alternative Strategy for Emergency Response Harbulcholizi, Luthfi; Malau, Jekmal; Alfiandri, Ihsan; Zulkifli, Iqbal; Rahmasari, Ratika
JPSCR: Journal of Pharmaceutical Science and Clinical Research Vol 10, No 3 (2025)
Publisher : Universitas Sebelas Maret

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20961/jpscr.v10i3.96215

Abstract

The global monkeypox (MPOX) outbreak, which has resulted in more than 100,000 confirmed cases across over 120 countries, underscores the urgent need for effective therapeutic strategies. MPOX, caused by a virus belonging to the Orthopoxvirus genus, poses significant clinical and public health challenges, particularly in regions with limited healthcare capacity. Although the World Health Organization declared MPOX a Public Health Emergency of International Concern in 2022, no specific antiviral treatment has yet been formally approved. While vaccination remains essential for long-term prevention, its impact is constrained by limited availability and unequal global distribution. Consequently, drug repurposing has emerged as a practical, rapid, and cost-efficient strategy to address immediate therapeutic demands during active outbreaks. This narrative review evaluates key repurposed antiviral agents including tecovirimat, brincidofovir, and cidofovir were originally developed for other Orthopoxvirus infections. A structured literature search using PubMed, ScienceDirect, and Google Scholar (2014–2024) identified studies providing clinically relevant evidence regarding their therapeutic roles in MPOX. Tecovirimat demonstrated consistent potential to improve viral clearance, shorten symptom duration, and reduce severe manifestations. Brincidofovir exhibited a more favorable safety profile, albeit with limited clinical data, whereas cidofovir showed antiviral activity but remains restricted by its nephrotoxicity. Collectively, current evidence suggests that drug repurposing offers a timely and resource-efficient option for managing MPOX and mitigating disease burden while vaccine accessibility continues to vary globally. When integrated with targeted public health interventions, repurposed drugs may serve as a crucial interim strategy to reduce transmission and enhance outbreak response capacity.
Co-Authors Alfiandri, Ihsan Harbulcholizi, Luthfi Irlina, Andi Jekmal Malau Rahmasari, Ratika